Christopher Viehbacher
Vorstandsvorsitzender bei
BIOGEN INC.
Vermögen: 26 Mio $ am 31.08.2026
Profil
Herr Christopher A. Viehbacher, CPA, ist Vorstandsvorsitzender bei PureTech Health Plc, Vorstandsvorsitzender bei Vedanta Biosciences, Inc. und Executive Chairman bei Boston Pharmaceuticals, Inc. sowie Managing Partner bei Gurnet Point Capital LLC. Er ist Mitglied des Verwaltungsrats von Zikani Therapeutics, Inc. und des CEO Roundtable on Cancer, Inc. sowie von Alladapt Immunotherapeutics, Inc. und BEFORE Brands, Inc. und der Northeastern University. Herr Viehbacher war zuvor als unabhängiger Direktor bei Axcella Health, Inc. tätig, als Vorsitzender bei der European Federation of Pharmaceutical Industries & Assns, als Vorsitzender bei Genzyme Corp, ein Mitglied von Pharmaceutical Research & Manufacturers of America, ein Chief Executive Officer & Director von Sanofi, ein Chairman & Chief Executive Officer von Glaxo Wellcome Plc, ein Director & Head-Pharmaceuticals Operations von GlaxoSmithKline Plc, ein Member-International Business Council von Forum Mondial de L'Economie, ein President von GlaxoSmithKline LLC, ein Vice Chairman von Nuvelution Pharma, Inc, ein Vorsitzender von Pfizer Inc., ein Principal von PricewaterhouseCoopers LLP, ein Chief Executive Officer von Sanofi-Aventis U.S. LLC und ein Mitglied von The International Business Council. Darüber hinaus war er Vorstandsmitglied bei Corium International, Inc, Innocoll Holdings Plc, Crossover Health, Inc, Healthcare Leadership Council, Research!America, The Burroughs Wellcome Fund und The Business Roundtable. Seinen Bachelor-Abschluss erhielt er an der Queen's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
1.08% | 07.08.2026 | 759’857 ( 1.08% ) | 19 Mio $ | 31.08.2026 |
BIOGEN INC. 0.02% | 21.04.2026 | 30’065 ( 0.02% ) | 7 Mio $ | 31.08.2026 |
Aktuelle Nachrichten zu Christopher Viehbacher
Aktive Positionen von Christopher Viehbacher
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOGEN INC. | Vorstandsvorsitzender | 14.11.2022 |
Zikani Therapeutics, Inc.
 Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Direktor/Vorstandsmitglied | 05.10.2017 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Private Equity Investor | - |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.01.2015 |
Project Data Sphere LLC
 Project Data Sphere LLC Data Processing ServicesTechnology Services Provides cancer clinical trial data sharing services | Direktor/Vorstandsmitglied | - |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Vorsitzender | 01.01.2015 |
sanofi-aventis Philippines, Inc.
 sanofi-aventis Philippines, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Direktor/Vorstandsmitglied | 01.12.2008 |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher Viehbacher
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Christopher Viehbacher
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
37
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 37 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Glaxo Wellcome Plc
 Glaxo Wellcome Plc Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and markets pharmaceuticals | Health Technology |
ERT Operating Co.
 ERT Operating Co. Data Processing ServicesTechnology Services Provides data solutions to clinical trials industry | Technology Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Zikani Therapeutics, Inc.
Zikani Therapeutics, Inc. Drugstore ChainsRetail Trade Focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens | Retail Trade |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
The Burroughs Wellcome Fund
 The Burroughs Wellcome Fund Investment Trusts/Mutual FundsMiscellaneous Operates an independent private foundation dedicated to advancing the medical sciences by supporting research and other scientific and educational activities | Miscellaneous |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Operates as political, business and cultural organizations | Commercial Services |
The Business Roundtable
 The Business Roundtable Miscellaneous Commercial ServicesCommercial Services Advocates public policies | Commercial Services |
CEO Roundtable on Cancer, Inc.
CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of novel neuroscience therapies | Health Technology |
Research!America
 Research!America Miscellaneous Commercial ServicesCommercial Services Operates as a lobbying firm | Commercial Services |
The International Business Council
 The International Business Council The International Business Council is a company based in Boston, MA. | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Crossover Health, Inc.
 Crossover Health, Inc. Medical/Nursing ServicesHealth Services Provides worksite health and wellness services | Health Services |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
PureTech Health Plc
 PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Nuvelution Pharma, Inc.
 Nuvelution Pharma, Inc. BiotechnologyHealth Technology Provides solutions for R&D companies in the pharmaceutical and biotech industries | Health Technology |
sanofi-aventis Philippines, Inc.
sanofi-aventis Philippines, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Innocoll Holdings Plc
 Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceuticals | Health Technology |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops therapies for patients | Commercial Services |
BEFORE Brands, Inc.
 BEFORE Brands, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Operates as a health and wellness company with products for young families | Consumer Non-Durables |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics targeting food allergy | Health Technology |
Project Data Sphere LLC
Project Data Sphere LLC Data Processing ServicesTechnology Services Provides cancer clinical trial data sharing services | Technology Services |
